Toggle light / dark theme

International research centre led by Jain 108 that offers a global curriculum of Sacred Geometry, Philosophical Geometry and Pyramid Mathematics. Online Courses presented by Jain 108 now available.

Black Holes are fascinating yet mysterious cosmic objects scattered across the Universe. Unfortunately, we don’t know much about them, and we barely managed to snap a photo of one located in another galaxy.

But, what exactly are black holes?

Per definition, a black hole is an astronomical object with such a strong gravitational pull that nothing, not even light, can escape from it. The “surface” of a black hole, called the event horizon, defines the limit where the speed required to evade it exceeds the speed of light, which is the speed limit in the cosmos. As a result, matter and radiation are trapped and cannot get out.

UPSIDE Foods (formerly Memphis Meats) has opened what it claims is the world’s most advanced cultivated meat production facility — and it wants you to stop by.

Cultivated meat: Demand for meat is higher than ever, but the process of raising and slaughtering livestock is bad for the environment (and arguably unethical), so transitioning away from it has a lot of upsides.

Most people really enjoy eating meat, though, and plant-based alternatives can’t quite replicate its taste and texture — but cultivated meat, advocates say, is the real deal.

Apple Inc. recently added audiobook narration to the growing list of occupations where algorithms are poised to replace humans alongside graphic designers, college essayists and limerick writers. Luckily, the fine art of newslettering remains (ahem) far beyond the capabilities of even the most sophisticated artificial intelligence software. Still, hope is at hand for those not fortunate enough to toil in the newsletter mines but still seeking gainful employment that won’t disappear as robots take control.


To remain employed in an AI-dominated workplace, train as an artisan.

U.S. health regulators gave early approval to a new Alzheimer’s drug from Eisai Co. and Biogen Inc., the most promising to date in a new class of medicines that may help slow cognitive decline caused by the disease.

The Food and Drug Administration granted conditional approval to the drug, called lecanemab, based on an early study finding it reduced levels of a sticky protein called amyloid from the brains of people with early-stage Alzheimer’s. The companies will sell it under the brand name Leqembi.